How historic housing policies affect health inequalities in mid-life.
The impact of redlining and place-based systemic racism on health inequalities at mid-life
This study looks at how old housing policies, like redlining, have affected the health of people in their middle years, aiming to understand how these policies have created health differences based on where people live.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11002278 on NIH RePORTER |
What this research studies
This research investigates how past housing policies, particularly redlining, have contributed to health disparities among mid-life individuals. By examining the social, economic, and behavioral factors linked to these policies, the study aims to understand their long-term impact on health outcomes. The researchers will create a national database that combines various data sources to analyze the relationship between neighborhood conditions and health access. This approach will help identify the mechanisms through which systemic racism has shaped health inequalities over time.
Who could benefit from this research
Good fit: Ideal candidates for this research are mid-life individuals living in neighborhoods historically impacted by redlining and systemic racism.
Not a fit: Patients living in areas not affected by historical redlining or those who do not experience health disparities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health policies that address and reduce health disparities in affected communities.
How similar studies have performed: Previous research has indicated that similar approaches to studying the impact of systemic racism on health outcomes have shown significant correlations, suggesting this research could build on established findings.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Meier, Helen Carmon Spink — University of Michigan at Ann Arbor
- Study coordinator: Meier, Helen Carmon Spink
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.